| pubmed-article:15837970 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:15837970 | lifeskim:mentions | umls-concept:C0030705 | lld:lifeskim |
| pubmed-article:15837970 | lifeskim:mentions | umls-concept:C0376358 | lld:lifeskim |
| pubmed-article:15837970 | lifeskim:mentions | umls-concept:C0003250 | lld:lifeskim |
| pubmed-article:15837970 | lifeskim:mentions | umls-concept:C0067685 | lld:lifeskim |
| pubmed-article:15837970 | lifeskim:mentions | umls-concept:C1310550 | lld:lifeskim |
| pubmed-article:15837970 | lifeskim:mentions | umls-concept:C1333570 | lld:lifeskim |
| pubmed-article:15837970 | lifeskim:mentions | umls-concept:C1312991 | lld:lifeskim |
| pubmed-article:15837970 | lifeskim:mentions | umls-concept:C0920321 | lld:lifeskim |
| pubmed-article:15837970 | pubmed:issue | 21 | lld:pubmed |
| pubmed-article:15837970 | pubmed:dateCreated | 2005-7-21 | lld:pubmed |
| pubmed-article:15837970 | pubmed:abstractText | To determine the maximum tolerated dose (MTD), toxicity, human anti-J591 response, pharmacokinetics (PK), organ dosimetry, targeting, and biologic activity of (177)Lutetium-labeled anti-prostate-specific membrane antigen (PSMA) monoclonal antibody J591 ((177)Lu-J591) in patients with androgen-independent prostate cancer (PC). | lld:pubmed |
| pubmed-article:15837970 | pubmed:grant | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:15837970 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:15837970 | pubmed:language | eng | lld:pubmed |
| pubmed-article:15837970 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:15837970 | pubmed:citationSubset | IM | lld:pubmed |
| pubmed-article:15837970 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:15837970 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:15837970 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:15837970 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:15837970 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:15837970 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:15837970 | pubmed:month | Jul | lld:pubmed |
| pubmed-article:15837970 | pubmed:issn | 0732-183X | lld:pubmed |
| pubmed-article:15837970 | pubmed:author | pubmed-author:MilowskyMatth... | lld:pubmed |
| pubmed-article:15837970 | pubmed:author | pubmed-author:NanusDavid... | lld:pubmed |
| pubmed-article:15837970 | pubmed:author | pubmed-author:KostakogluLal... | lld:pubmed |
| pubmed-article:15837970 | pubmed:author | pubmed-author:Vallabhajosul... | lld:pubmed |
| pubmed-article:15837970 | pubmed:author | pubmed-author:GoldsmithStan... | lld:pubmed |
| pubmed-article:15837970 | pubmed:author | pubmed-author:BanderNeil... | lld:pubmed |
| pubmed-article:15837970 | pubmed:issnType | Print | lld:pubmed |
| pubmed-article:15837970 | pubmed:day | 20 | lld:pubmed |
| pubmed-article:15837970 | pubmed:volume | 23 | lld:pubmed |
| pubmed-article:15837970 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:15837970 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:15837970 | pubmed:pagination | 4591-601 | lld:pubmed |
| pubmed-article:15837970 | pubmed:dateRevised | 2011-8-1 | lld:pubmed |
| pubmed-article:15837970 | pubmed:meshHeading | pubmed-meshheading:15837970... | lld:pubmed |
| pubmed-article:15837970 | pubmed:meshHeading | pubmed-meshheading:15837970... | lld:pubmed |
| pubmed-article:15837970 | pubmed:meshHeading | pubmed-meshheading:15837970... | lld:pubmed |
| pubmed-article:15837970 | pubmed:meshHeading | pubmed-meshheading:15837970... | lld:pubmed |
| pubmed-article:15837970 | pubmed:meshHeading | pubmed-meshheading:15837970... | lld:pubmed |
| pubmed-article:15837970 | pubmed:meshHeading | pubmed-meshheading:15837970... | lld:pubmed |
| pubmed-article:15837970 | pubmed:meshHeading | pubmed-meshheading:15837970... | lld:pubmed |
| pubmed-article:15837970 | pubmed:meshHeading | pubmed-meshheading:15837970... | lld:pubmed |
| pubmed-article:15837970 | pubmed:meshHeading | pubmed-meshheading:15837970... | lld:pubmed |
| pubmed-article:15837970 | pubmed:meshHeading | pubmed-meshheading:15837970... | lld:pubmed |
| pubmed-article:15837970 | pubmed:meshHeading | pubmed-meshheading:15837970... | lld:pubmed |
| pubmed-article:15837970 | pubmed:meshHeading | pubmed-meshheading:15837970... | lld:pubmed |
| pubmed-article:15837970 | pubmed:meshHeading | pubmed-meshheading:15837970... | lld:pubmed |
| pubmed-article:15837970 | pubmed:year | 2005 | lld:pubmed |
| pubmed-article:15837970 | pubmed:articleTitle | Phase I trial of 177lutetium-labeled J591, a monoclonal antibody to prostate-specific membrane antigen, in patients with androgen-independent prostate cancer. | lld:pubmed |
| pubmed-article:15837970 | pubmed:affiliation | Department of Urology, Weill Medical College of Cornell University, 525 E 68th St, E-300, New York, NY 10021, USA. nhbander@med.cornell.edu | lld:pubmed |
| pubmed-article:15837970 | pubmed:publicationType | Journal Article | lld:pubmed |
| pubmed-article:15837970 | pubmed:publicationType | Clinical Trial | lld:pubmed |
| pubmed-article:15837970 | pubmed:publicationType | Research Support, U.S. Gov't, P.H.S. | lld:pubmed |
| pubmed-article:15837970 | pubmed:publicationType | Research Support, Non-U.S. Gov't | lld:pubmed |
| pubmed-article:15837970 | pubmed:publicationType | Clinical Trial, Phase I | lld:pubmed |
| pubmed-article:15837970 | pubmed:publicationType | Research Support, N.I.H., Extramural | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:15837970 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:15837970 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:15837970 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:15837970 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:15837970 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:15837970 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:15837970 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:15837970 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:15837970 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:15837970 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:15837970 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:15837970 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:15837970 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:15837970 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:15837970 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:15837970 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:15837970 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:15837970 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:15837970 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:15837970 | lld:pubmed |
